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Malaysian HEV isolatea b s t r a c t
Background: Zoonotically acquired HEV has been described as one of the most successful zoonotic viral
infections in human history.
Aim: In this study we characterized HEV comparative genomic analysis as it relates to swine HEV.
Materials and methods: A total of 82 chronic hepatitis B patients were recruited from May 2015 to May
2016 for this study. We conducted a serological and molecular investigation of HEV among these patients.
The detected HEV were sequenced and the genomes and deduced amino acids were characterized using
molecular evolutionary genetic analysis software version 7.
Results: Of the 82 chronic hepatitis B patients that were tested, 9.8% (8/82) were found to be HEV pos-
itive. Phylogenetic analysis of the HEV RNA sequences showed they are of genotype 4 and demonstrated
high sequence identity with a swine isolate from China, with variation in amino acids at position 22,
where leucine was present in the Malaysian human isolate while phenylalanine was present in the
China swine isolate.
Conclusion: Comparative analysis of the human HEV ORF-2 nucleotide sequence suggest zoonotic
origin.
 2017 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hepatitis E virus (HEV) is distributed worldwide, infecting
about two billion people with 14 million symptomatic infections
and an annual mortality of 300,000. Hepatitis E viral infection in
developing countries is endemic, but an increasing number of spo-
radic as well as authochronous infections have been reported in
recent years.1 According to the Southeast Asia Regional Office of
the World Trade Organization (WTO), Asia hosts 6.5 million symp-
tomatic HEV infections with 160,000 annual mortalities and 2700
stillbirths due to HEV infection in pregnancy. As such, more than
50% of the global HEV infection mortality occurs in Asia.2 Hepatitis
E virus is transmitted enterically leading to self-limiting acute viralhepatitis infection with no chronic stage.3 However, in some cases,
fulminant hepatic failure can result, leading to increases in mor-
bidity and mortality, especially among high risk groups such as,
pregnant women immunocompromised, elderly people and pre-
existing liver diseases patients such as with chronic hepatitis B
or C infections.4–6
Zoonotic potential of HEV has been reported in a previous study
in which HEV antibodies was found in animal serum.7,8 For
instance, some HEV cases in Japan were found to be directly asso-
ciated with eating raw or under cooked deer meat,9 while several
cases of HEV were epidemiologically linked to consumption of
poorly cooked wild boar meat or pork.10–12 HEV was reported to
be successfully transmitted from animal to human,1 as it causes
acute infection as well as aggravates any existing chronic hepatitis
condition. Malaysia is a multicultural and multi-ethnic society, and
a center for tourist attraction and business investment. It is there-
fore important to study the possible risk of HEV transmission in
relation to possible zoonosis.
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2.1. Study population
Chronic hepatitis B patients that present with cirrhosis, non-
cirrhosis or acute flare ups seen by or admitted to the Hepatology
Department of Hospital Selayang who consented to the study were
recruited. However, patients with non-hepatitis B liver cirrhosis or
non-cirrhotic liver disease and those with HIV co-infection were
excluded from the study.
2.2. Ethical consideration
Ethical approval to conduct this study was obtained from the
Malaysian Medical Research Institute (NMRR-14-1136-21909)
and the Malaysian Medical Research and Ethic Committee
(KKM/NIHSEC/P15-63) as well as the Universiti Putra Malaysia
Human Ethic Committee (UPM/TNCPI/RMC/JKEUPM/1.4.18.1/F1).
Signed informed consent was obtained from the patients by the
attending physician.
2.3. Sample collection
A total of 82 patients were recruited from May 2015 to May
2016. Ten millilitres of blood was collected from each patient into
an EDTA blood collecting tube, and the plasma was separated
immediately after collection and kept in 80 C before performing
experiment.
2.4. Serological assay
Hepatitis E virus antibodies (IgM and IgG) were determined
using enzyme linked immunosorbent assay (ELISA) according to
manufacturer’s instructions (Wantai Bio-Pharm., Beijing, China).
Briefly, both reagents and the frozen plasma were allowed to reach
room temperature. Into the microplate ELISA well, 50 ml of sample
diluent was added except the blank well. Both the plasma sample
and the controls were also added to the diluents and mixed by gen-
tle tapping. The mixture was then covered and incubated for
30 min at 37 C, followed by 45 s soaking periods and washing five
times. Horse radish peroxidase (HRP) was added and incubated at
37 C for 30 min followed by washing five times as mentioned ear-
lier. Fifty microliters each of chromogen A and B solution was
added to the entire well, including the blank and incubated for
15 min at 37 C, followed by adding 50 ml stop solution and the
absorbance was measured using TECAN sunrise (Männedorf,
Switzerland) microplate absorbance reader at a reference wave-
length of 630 nm.
2.5. HEV RNA isolation
Hepatitis E viral RNA was extracted from the patients’ plasma
using QIAamp RNA blood mini kit as described by the manufac-
turers (Qiagen, Hilden, Germany). Concisely, 20 ml protease was
added to the bottom of 1.5 ml tube, followed by addition of
200 ml plasma. Buffer AL was added to all of the samples and
was mixed thoroughly for 15 s by pulse-vortexing after which it
was incubated for 10 min at 56 C using a water bath. After incu-
bation, 200 ml of ethanol was added to the sample and was vor-
texed for 15 s. The mixture was then emptied into 2 mL
QIAamp mini columns and centrifuged at 8000 rpm for 60 min,
after which the follow through was discarded. Washing step
was performed by adding 500 ml of washing buffer AW1 and cen-
trifuged at 8000 rpm for 60 min, followed by AW2 buffer cen-
trifuged at 14,000 rpm for three minutes. The RNA was theneluted by adding 50 ml of elution buffer, and the RNA recovered
was kept at 70 C. The RNA concentration was determined by
the NanoDrop ND-1000A spectrophotometer (NanoDrop Tech-
nologies Inc.). The purity of the sample was determined by using
the A260/A280 ratio to determine its purity.2.6. HEV RNA detection and sequencing
Two published primers were used for the outer and inner poly-
merase chain reaction (PCR). The outer primers are: HEV-R-Outer
(50CCCTTATCCTGCTGAGCATTCTC-30) and HEV-R-Outer (50-AAY
TATGCWCAGTACCGGGTTG-30), and the nested or inner primers
are: HEV-F-Inner (50-GTYATGYTYTGCATACATGGCT-30) and HEV-
R-Inner (50-AGCCGACGAAATYAATTCTGTC-30). The primers were
commercially synthesised (IDT) and were used to amplify the tar-
geted HEV ORF-2 region.13
The RT-PCR was performed using Access kit according to man-
ufacturer’s instruction (Promega, USA). The reaction mixture was
prepared in a 50 ml thin wall tube, and the reverse transcription
was performed at 50 C for 30 min, followed by 35 cycles of ampli-
fication at 94 C for 1 min, 50 C for 45 s, and 72 C for 1minute,
with a final extension of 72 C for 10 min. The amplification pro-
duct of the RT-PCR was used as template for nested PCR using
the inner primers. Both the reaction mixture volume and the PCR
conditions used for the nested PCR are the same as that of the first
round described above. The amplified nested PCR products were
analysed using gel electrophoresis and visualised using gel Doc.
(BioRAD), with a final amplification product of 345 bp.2.7. Sequence analysis
The partial HEV ORF2 region from the eight Malaysian HEV
strains was subjected to a nucleotide BLAST search for sequence
homology. The phylogenetic study was done by comparing the
Malaysian HEV sequence with reference isolates from humans,
pigs and wild boars retrieved from national center for biotechnol-
ogy information (NCBI) gene data base. All eight sequences were
submitted to the gene bank and were assigned accession numbers
from KX426575 to KX426582. The maximum likelihood (ML) phy-
logenetic method was performed with the aid of MEGA7 soft-
ware14 for genotyping and sequence relatedness with reference
human and animal strains of HEV from different sources. Model
with the lowest Bayesian criterion information explaining substi-
tution pattern among nucleotide sequences is considered the best
model15 and was considered during sequence analysis. The relia-
bility of the phylogenetic tree was determined using bootstrap-
ping16 Evolutionary divergence between sequences was
estimated using the ML model. Amino acids deduced from nucleo-
tide sequences of our isolate and that of a reference isolate from
swine hepatitis were aligned using the Biological Sequence Align-
ment Editor, v 7.2.0 (BioEdit)17 bioinformatics software to deter-
mine the amino acid differences between the human and swine
HEV isolates.2.8. Data analysis
Statistical analysis to determine the proportion of HEV infection
among the study population and their demographic profile was
done using statistical package for social science version 22.0 (SPSS,
Inc., Chicago). Sequence analysis and phylogeny was performed
using Molecular Evolutionary Genetic Analysis (MEGA5)
software.14
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Of the 82 chronic hepatitis B patients that were tested for anti-
bodies against HEV, 59.8% (49/82) were male. The distribution
according to ethnicity was 32.9% (27/82) Malay, 62.2% (51/82) Chi-
nese, 3.7% (3/82) Indian and 1.2% (1/82) Orang Asli. Half (41/82) of
the patients were older than 50 year of age and only 11% (9/82)
were below 30 years of age
the remaining 39% (32/82) of patients were between 30 and
49 years of age. 9.8% (8/82) were found to be positive. Most of
the HEV-seropositive patients were 61 years old and older (75%),
followed by those within the age group of 51–60 years. Out of
the eight hepatitis E infected patients, five were males (62.5%)
and three females (37.5%), and all of them were Chinese. Hepatitis
E virus RT-PCR was positive for all eight seropositive samples, and
sequencing of the amplified PCR product confirmed the genome to
be HEV. Phylogenetic analysis of this sequence confirmed that it
was genotype 4 (Fig. 1) based on evolutionary history inferred by
maximum likelihood according to the Hasegawa-Kishino model.
The HEV ORF-2 nucleotide sequence homology between Malay-
















Fig. 1. Hepatitis E virus genotyping by molecular phylogenetic analysis. The evolution
Hasegawa-Kishino-Yano.18 The tree has the highest likelihood (2728.90830) and su
evolutionary modelling (+G, parameter = 0.2081). The tree is drawn to scale 0.1, with
indicate Malaysian isolates belonging to genotype 4. G1, G2, G3, and G4 indicate genoty96%, respectively. Homology of the Malaysian sequences in terms
of geographical relatedness to other Southeast Asian countries
revealed most of the Malaysian isolates are closely related to refer-
ence isolates from Laos, India and Thailand among others. How-
ever, one of the Malaysian isolates, HSA14, differed from the
others and is related to isolates from Japan, Nepal and China. Phy-
logenetic analysis revealed that the Malaysian HEV sequences are
placed in two distinct clusters with the majority (7/8) grouped in
a single cluster, and they are phylogenetically related to isolates
from Thailand, Laos and India. Furthermore, the remaining one
Malaysian isolate was grouped with other reference isolates in a
different cluster (Fig. 2).
Interestingly, the Laos and Thailand isolates were from pigs and
belong to genotypes 4 and 3, respectively, while the Indian isolate
was from human serum and belongs to genotype 1 (Table 1).
Malaysian isolates HSA14, 23 and 45 demonstrated high
sequence identity with a swine isolate, SAAS-FX17 (JF915746),
from China (96.7%, 99% and 94.1%, respectively), while isolate
HSA75 was found to be 89.3% identical to swine isolate IND-SW-
00-01 (AY723745) from India (Table 2). The evolutionary
relatedness of these isolates as inferred by Neighbor-Joining HEV HSA37 KX426577
 HEV HSA45 KX426578
 HEV HSA60 KX426579
 HEV HSA14 KX426575
 HEV HSA23 KX426576
 HEV HSA69 KX426580
 HEV-AB108537.1G4






















ary relationship was inferred using maximum likelihood based on the model by
perior log likelihood and topology. A distinct Gamma distribution was used in
the branch length measured in the number of substitutions per site. The red dots
pe 1, 2, 3 and 4 respectively.
Fig. 2. Molecular phylogenetic analysis of 63 nucleotide sequences which involved the first, second, third, and noncoding codon positions for a total of 4504 positions.
Geographical relatedness of our Malaysian sequences (red dot), with representative sequences of Southeast Asia Countries, separate into two distinct clusters (Red and Blue).
The Maximum likelihood molecular phylogenetic analysis method was used to infer the evolutionary history of this isolate based on the model by Hasegawa-Kishino-Yano18
with discrete Gamma distribution (+G, parameter = 1.0457) to model the evolutionary diversities among sites. The tree was obtained using Maximum likelihood and the
topology with the superior log likelihood value was selected. The evolutionary analysis was performed in MEGA7.14
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phylogenetic tree as shown in Fig. 3.
This evolutionary relationship was computed using the Kimura
2-parameter model with gamma distribution. Further bioinformat-
ics analysis revealed that nucleotide substitution as well as
transversion rates showed that transition and transversion
occurred most with cytosine and thymine (25.11%), followed by
substitutions between thymine and guanine (19.34%). Amino acid
sequence analysis of our isolates compared to a reference swine
HEV from China which exhibited 99% similarity with our
sequences showed that our isolates had 3 to 11 amino acid varia-
tions from the swine HEV at different positions of the gene. How-
ever, all the Malaysian isolates shared an amino acid difference at
position 22 of the ORF-2 gene where phenylalanine (F) in swineHEV was replaced by leucine (L) in human HEV (Fig. 4a). On the
other hand, when compared with the Indian isolate with the low-
est sequence similarity (89.3%), our Malaysian isolates showed
more variations in amino acids than the China swine isolates but
shared an amino acid variation at six different positions: D37G,
S78P, T124V, A574T, V620A and T625V. The lowest number of
amino acid differences from this Indian isolate was found in the
Malaysian isolate KX426582, which differed from the Indian swine
isolate by only 11 amino acids (Fig. 4b).
4. Discussion
This study provides strong evidence based on bioinformatics
that HEV isolated from chronic hepatitis B patients in Malaysia
Table 1
Genetic distribution of some Southeast Asian HEV isolates used in phylogenetic geographical relatedness with the Malaysian isolate. The Myanmar isolate genotype was not
confirmed (–).
Accession Organism Country Isolate Sample source Genotype
KT447528 Hepatitis E virus Singapore Sing-HEV23 Human Serum 3
KT447527 Hepatitis E virus Singapore Sing-HEV20 Human Serum 3
KT447526 Hepatitis E virus Singapore Sing-HEV01 Human Serum 3
KJ522883 Hepatitis E virus India JBGU37 Human Serum 1
KC819417 Hepatitis E virus India HC-7 Human Blood 1
KC819416 Hepatitis E virus India HC-6 Human Blood 1
JN705659 Hepatitis E virus India SHV9 Human Plasma 1
JN705658 Hepatitis E virus India SHV8 Human Plasma 1
JN542515 Hepatitis E virus China YN11-2 Human Faeces 4
JN542514 Hepatitis E virus China YN11-1 Human Faeces 4
JN052926 Hepatitis E virus China SHEV-JX1 Human Bile 4
JN039377 Hepatitis E virus China SHEV-JX Human Bile 4
HM244409 Hepatitis E virus China GY0108 Human Plasma 4
FJ438396 Hepatitis E virus Hong Kong HK4-2006 Human Blood 4
FJ438395 Hepatitis E virus Hong Kong HK1-2007 Human Blood 4
AB499901 Hepatitis E virus Japan HE-0701982 Human Serum 3
AB499900 Hepatitis E virus Japan HE-0624158 Human Serum 3
AB292650 Hepatitis E virus Japan HE-JTB95-1 Human Serum 3
AB292649 Hepatitis E virus Japan HE-JTB94-1 Human Serum 4
AB288358 Hepatitis E virus Japan HE-JSB1564 Human Serum 3
AB085949 Hepatitis E virus Nepal Ne014 Human Serum 1
KJ645948 Hepatitis E virus Philippines Mor_PHL_2010_Tjs-148 Swine Faeces 3
KJ645947 Hepatitis E virus Philippines Mor_PHL_2010_Tjs-142 Swine Faeces 3
KJ645946 Hepatitis E virus Philippines Vil_PHL_2010_Tjs-130 Swine Faeces 3
KF546275 Hepatitis E virus Philippines Philippines-HEV-4-6 River 3
KF546274 Hepatitis E virus Philippines Philippines-HEV-4-8 River 3
AY858896 Hepatitis E virus Thailand T2-9s Swine Serum 3
AY858895 Hepatitis E virus Thailand T2-7s Swine Serum 3
AY858894 Hepatitis E virus Thailand T2-5s Swine Serum 3
AY858893 Hepatitis E virus Thailand T2-4s Swine Serum 3
KP886949 Hepatitis E virus Thailand Th-Hu-2014-TM Swine Serum 3
EU274577 Hepatitis E virus Cambodia CAM-REP-R1 River Water 3
DQ145794 Hepatitis E virus Cambodia CAM-3F2s Human Serum 3
DQ145793 Hepatitis E virus Cambodia CAM-3F13 Human Faeces 3
DQ145792 Hepatitis E virus Cambodia CAM-H8 Human Serum 3
DQ145799 Hepatitis E virus Cambodia CAM-3F15 Human Faeces 1
AB714132 Hepatitis E virus Indonesia YKSB51 Swine Serum 3
AB714131 Hepatitis E virus Indonesia YKSB26 Swine Serum 3
AB714130 Hepatitis E virus Indonesia YKSF25 Swine Faeces 3
AB714129 Hepatitis E virus Indonesia YKSF24 Swine Faeces 3
AB714128 Hepatitis E virus Indonesia YKSF23 Swine Faeces 3
AB168096 Hepatitis E virus Viet Nam HE-JVN1 Human Serum 4
AB168095 Hepatitis E virus Viet Nam HE-JVN1 Human Serum 4
AB075968 Hepatitis E virus Viet Nam V123ORF1 Human Serum 4
AB075967 Hepatitis E virus Viet Nam V091ORF1 Human Serum 4
AB075966 Hepatitis E virus Viet Nam V013ORF1 Human Serum 4
HQ541431 Hepatitis E virus Laos XK59803 Swine Faeces 4
HQ541430 Hepatitis E virus Laos XK59802 Swine Faeces 4
HQ541429 Hepatitis E virus Laos XK59801 Swine Faeces 4
HQ541428 Hepatitis E virus Laos XK24507 Swine Faeces 4
HQ541427 Hepatitis E virus Laos O67402 Swine Faeces 4
LC088983 Hepatitis E virus Myanmar Rat-RM97 Liver Tissue –
LC088982 Hepatitis E virus Myanmar Rat-RM96 Liver Tissue –
LC088981 Hepatitis E virus Myanmar Rat-RM93 Liver Tissue –
LC088980 Hepatitis E virus Myanmar Rat-RM88 Liver Tissue –
KX426575 Hepatitis E virus Malaysia HEV HSA14 Human Plasma 4
KX426576 Hepatitis E virus Malaysia HEV HSA23 Human Plasma 4
KX426577 Hepatitis E virus Malaysia HEV HSA37 Human Plasma 4
KX426578 Hepatitis E virus Malaysia HEV HSA45 Human Plasma 4
KX426579 Hepatitis E virus Malaysia HEV HSA60 Human Plasma 4
KX426580 Hepatitis E virus Malaysia HEV HSA69 Human Plasma 4
KX426581 Hepatitis E virus Malaysia HEV HSA75 Human Plasma 4
KX426582 Hepatitis E virus Malaysia HEV HSA77 Human Plasma 4
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mission of HEV for the first time in Malaysia. Before now, only
seroprevalence of HEV was reported from among Malaysian Orang
Asli from Parit Tanjung and Betau which had a prevalence of 44
and 50%, respectively, while on the other hand the prevalence
was lower among blood donors in Kuala Lumpur (2%).19 However,
in this study, HEV prevalence was found to be 9.8% among
Malaysian chronic hepatitis B patients. All the eight HEV antibodypositive samples were found to be positive for HEV RNA. This is a
clear demonstration that the rate of infection within a single coun-
try can vary significantly, from 2% in urban blood donors to 50% in
aboriginal populations and 9.8% in chronic hepatitis B patients as
found in this study. This suggests the need for a comprehensive
study to evaluate the prevalence of HEV in general population for
effective control measures. Similarly, in Netherland, an 11% HEV
prevalence was found in those exposed to swine, with a prevalence
Table 2
Estimation of sequence evolutional divergence between our Malaysian isolates from
humans and the reference isolates from animals. The Kimura 2-parameter model was
used to analyse the number of base substitutions. The variation rate amongst the
sequences was modelled with a gamma distribution and all gabs and missing data











































































Fig. 3. Evolutionary relatedness of our Malaysian isolates (red dot) with swine and
boar sequences inferred by Neighbor-Joining. The tree branches shown are optimal
with a branch length sum of 4.43261981. The evolutionary diversities were
computed via the Kimura 2-parameter based on the number of substitutions per
site. The variation among sites was modelled by gamma distribution.
Fig. 4. Deduced amino acid alignments of the Malaysian (MY) human HEV isolate with a reference swine HEV: (a) the dots indicate common amino acids with the reference
isolate. Reference swine isolate from China. The red box indicates a site of an amino acid difference shared by all of the Malaysian isolates (F22L) with the reference isolate. (b)
The dots indicate common amino acids with the reference isolate. The black boxes indicate a site of an amino acid difference shared by all of the Malaysian isolates with the
reference isolate. Where F = Phenylalanine, L = Leucine, T = Threonine, S = Serine, G = Glycin, A = Alanine, V = Valine, Q = Glutamine, N = Asparagine, P = Proline, I = Isoleucine,
M = Methionine, Y = Tyrosine, D = Aspartic acid.
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Fig. 5. Deduced amino acid alignments of the Malaysian isolate with a reference swine HEV capsid protein from India. The red boxes indicate a site of shared amino acid of
the Malaysian isolates with the reference swine isolate. Where F = Phenylalanine, L = Leucine, T = Threonine, S = Serine, G = Glycine, A = Alanine, V = Valine, Q = Glutamine,
N = Asparagine, P = Proline, I = Isoleucine, M = Methionine = Tyrosine.
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exposure to swine. Several studies reported a higher HEV preva-
lence in males compared to females, such as 49.8% and 44.9% in
Nepal and 52.6% and 47.4% in Bangladesh.21 Similarly, our results
also revealed a higher prevalence in males (62.5%) than in females
(37.5%). Most of the patients with HEV in this study were 61 years
of age and older (75%), which is in agreement with the findings
from previous studies.12,22 The racial aligning of HEV to Chinese
in this studymight not be surprising due the fact that they consume
pork. Pigs, wild boar and rats have been shown experimentally to be
associatedwithHEV strain that affects humans.23–25 Swine hepatitis
E virus has since been discovered to cross reacts with human HEV
antibodies.26 This significantly raises the public health concern for
a zoonotic transmission, which is greatly supported by the finding
in this study which shows that the Malaysian human HEV isolates
have high sequence identity (89–99%) to swine and boar HEV. Sim-
ilarly, the zoonotic potential of HEV has also been reported in the
United States of America,27 which shows that non endemic coun-
tries can also have zoonotic transmission of HEV.28
In this study, the phylogenetic analysis was based on the ORF-2
nucleotides and confirmed for the first time that the Malaysian iso-
lates were of genotype 4. Studies have shown that genotype 3 and
4 have zoonotic reservoir while genotype 1 and 2 are exclusively
human pathogens.29 Similarly, genotypes 1 and 4 were found in
China,30 genotype 2 in Mexico31 and Nigeria32 and genotype 3
the United States of America.33 However, Malaysian isolates
HSA14, 23 and 45 revealed high sequence identity with a swine
isolate, SAAS-FX17 (JF915746), from China (96.7%, 99% and 94.1%,
respectively) which also belongs to genotype 4. Similarly, isolate
HSA75 was also found to be 89.3% identical to swine isolate
(AY723745) of India and also belong to genotype 4. When the
amino acid analysis of our Malaysian isolate was compared with
the China swine isolate that had the highest identity (99%) to our
isolate, it was found that they only differed by an average of eight
amino acids. This shows how close the Malaysian HEV isolate is
with the China swine isolate JF915746. The amino acid variation
that is common to all of our Malaysian isolates was found to be
at position 22, where leucine was present in the Malaysian human
isolate while phenylalanine was present in the China swine iso-
lates. On the other hand, an Indian swine isolate AY23745 with
the least (89.3%) similarity to our Malaysian human isolate showedmore amino acid variation at various positions of the ORF-2 pro-
tein. The lowest number of amino acid differences was found in
Malaysian isolate KX426582, which differed from the Indian swine
HEV by just eleven amino acids. All the Malaysian isolates shared
amino acid differences with the Indian swine isolates at the follow-
ing positions: at 37 swine aspartic acid was replaced by glycine in
human HEV (D37G), at 78 swine serine was replaced by proline in
human HEV (S78P), at 124 swine threonine was replaced by valine
in human HEV (T124V), at 574 swine alanine was replaced by thre-
onine in human HEV (A574T), at 620 swine valine was replaced by
alanine in human HEV (V620A) and at 625 swine threonine was
replaced by valine in human HEV, as shown in Fig. 5.
Although these Malaysian isolates resemble the Chinese and
Indian isolates, all were from Malaysians whose history of travel
to China and India was not ascertained. Nonetheless, it is still pos-
sible that these isolates were imported from China and India,
because of importation of many possible vehicles of transmission
such as canned foods, pork meats as well as immigration of people
from these and other Asian countries to Malaysia for tourism or
business. A wider understanding of the risk and prevalence of
HEV associated with swine in the Southeast Asia region could be
of public health importance and essential in food safety
intervention.
5. Conclusion
This study revealed that 9.8% of chronically infected HBV
patients were co-infected with HEV. Comparative genomic
sequence analysis of our isolates suggests a zoonotic origin, with
sequence identity ranging from 89% to 99% with swine and boar
HEV. Since HEV is capable of causing fulminant hepatic failure in
patients with pre-existing liver diseases, it will therefore be of
significant benefit to screen all chronic hepatitis B patients of
HEV co-infection in order to provide effective patient management
and disease prevention.
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